{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:25:52Z","timestamp":1755217552551,"version":"3.43.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.therap.2024.12.010","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T11:57:58Z","timestamp":1736251078000},"page":"469-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact d\u2019une rupture de dronabinol sur une population de patients douloureux chroniques\u00a0: \u00e9tude observationnelle r\u00e9trospective"],"prefix":"10.1016","volume":"80","author":[{"given":"Salom\u00e9","family":"Winckel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Ferret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lie","family":"Boursier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"Legifrance. Arr\u00eat\u00e9 du 16\u00a0octobre 2020\u00a0fixant les sp\u00e9cifications des m\u00e9dicaments \u00e0 base de cannabis utilis\u00e9s pendant l\u2019exp\u00e9rimentation pr\u00e9vue \u00e0 l\u2019article 43\u00a0de la loi no\u00a02019-1446\u00a0du 24\u00a0d\u00e9cembre 2019\u00a0de financement de la s\u00e9curit\u00e9 sociale pour 2020, les conditions de leur mise \u00e0 disposition ainsi que les indications th\u00e9rapeutiques ou situations cliniques dans lesquelles ils seront utilis\u00e9s. 2019. https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000042434518\/ [Consult\u00e9 le 27\u00a0d\u00e9cembre 2024].","key":"10.1016\/j.therap.2024.12.010_bib0135"},{"unstructured":"ANSM. Dossier th\u00e9matique\u00a0\u2013\u00a0cannabis \u00e0 usage m\u00e9dical\u00a0: professionnels de sant\u00e9\u00a0: formation, prescription. 2021. https:\/\/ansm.sante.fr\/dossiers-thematiques\/cannabis-a-usage-medical\/professionnels-de-sante-formation-prescription-dispensation [Consult\u00e9 le 27\u00a0d\u00e9cembre 2024].","key":"10.1016\/j.therap.2024.12.010_bib0140"},{"unstructured":"ANSM. Comit\u00e9 scientifique temporaire\u00a0: \u00ab\u00a0Suivi de l\u2019exp\u00e9rimentation fran\u00e7aise de l\u2019usage m\u00e9dical du cannabis\u00a0\u00bb. Octobre 2022. https:\/\/ansm.sante.fr\/evenements\/comite-suivi-de-lexperimentation-francaise-de-lusage-medical-du-cannabis-15 [Consult\u00e9 le 27\u00a0d\u00e9cembre 2024].","key":"10.1016\/j.therap.2024.12.010_bib0145"},{"key":"10.1016\/j.therap.2024.12.010_bib0150","first-page":"CD012182","article-title":"Cannabis-based medicines for chronic neuropathic pain in adults","volume":"3","author":"M\u00fccke","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"unstructured":"ANSM. Protocole d\u2019utilisation therapeutique et de recueil de donnees\u00a0: Marinol 2,5\u00a0mg, capsule molle (dronabinol). 2023. https:\/\/ansm.sante.fr\/tableau-acces-derogatoire\/dronabinol-usp# [Consult\u00e9 le 27\u00a0d\u00e9cembre 2024].","key":"10.1016\/j.therap.2024.12.010_bib0155"},{"key":"10.1016\/j.therap.2024.12.010_bib0160","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/pm\/pnac010","article-title":"Effectiveness and tolerability of dronabinol use in patients with chronic pain: a retrospective analysis of 12-week open-label real-world data provided by the German pain e-registry","volume":"23","author":"Ueberall","year":"2022","journal-title":"Pain Med"},{"key":"10.1016\/j.therap.2024.12.010_bib0165","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12916-022-02459-1","article-title":"Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications","volume":"20","author":"Bilbao","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.therap.2024.12.010_bib0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00482-015-0089-y","article-title":"Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: a systematic review of randomized controlled studies","volume":"30","author":"Petzke","year":"2016","journal-title":"Schmerz"},{"key":"10.1016\/j.therap.2024.12.010_bib0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3959(83)90143-4","article-title":"Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases","volume":"17","author":"Daut","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.therap.2024.12.010_bib0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.pain.2003.12.024","article-title":"Development and validation of the neuropathic pain symptom inventory","volume":"108","author":"Bouhassira","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.therap.2024.12.010_bib0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.therap.2024.12.010_bib0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/2374373518786013","article-title":"Impact of chronic pain on patients\u2019 quality of life: a comparative mixed-methods study","volume":"6","author":"Hadi","year":"2019","journal-title":"J Patient Exp"},{"key":"10.1016\/j.therap.2024.12.010_bib0195","doi-asserted-by":"crossref","first-page":"1253460","DOI":"10.3389\/fpain.2023.1253460","article-title":"Chronic pain: its impact on the quality of life and gender","volume":"4","author":"Pandelani","year":"2023","journal-title":"Front Pain Res (Lausanne)"},{"key":"10.1016\/j.therap.2024.12.010_bib0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41386-019-0439-z","article-title":"Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications","volume":"45","author":"Haack","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.therap.2024.12.010_bib0205","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/pm\/pnz343","article-title":"Chronic pain and sleep disturbances: a pragmatic review of their relationships, comorbidities, and treatments","volume":"21","author":"Husak","year":"2020","journal-title":"Pain Med"},{"key":"10.1016\/j.therap.2024.12.010_bib0210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/AJP.0000000000000260","article-title":"A critical review of neurobiological factors involved in the interactions between chronic pain, depression, and sleep disruption","volume":"32","author":"Boakye","year":"2016","journal-title":"Clin J Pain"},{"key":"10.1016\/j.therap.2024.12.010_bib0215","doi-asserted-by":"crossref","first-page":"e0215837","DOI":"10.1371\/journal.pone.0215837","article-title":"The impacts of medication shortages on patient outcomes: a scoping review","volume":"14","author":"Phuong","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.therap.2024.12.010_bib0220","doi-asserted-by":"crossref","first-page":"693426","DOI":"10.3389\/fphar.2021.693426","article-title":"Drug shortage: causes, impact, and mitigation strategies","volume":"12","author":"Shukar","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.therap.2024.12.010_bib0225","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/bcp.15550","article-title":"Adverse drug reaction related to drug shortage: a retrospective study on the French National Pharmacovigilance Database","volume":"89","author":"Bourneau-Martin","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.therap.2024.12.010_bib0230","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/epi.13974","article-title":"A longitudinal cohort study on the impact of the clobazam shortage on patients with epilepsy","volume":"59","author":"Lukmanji","year":"2018","journal-title":"Epilepsia"},{"unstructured":"S\u00e9nat. P\u00e9nurie de m\u00e9dicaments\u00a0: trouver d\u2019urgence le bon rem\u00e8de. 2023\u00a0juillet. https:\/\/www.senat.fr\/notice-rapport\/2022\/r22-828-1-notice.html [Consult\u00e9 le 27\u00a0d\u00e9cembre 2024].","key":"10.1016\/j.therap.2024.12.010_bib0235"},{"unstructured":"Rabaut V. Lutte contre les p\u00e9nuries de m\u00e9dicaments. 2024. https:\/\/www.senat.fr\/dossier-legislatif\/ppl23-375.html [Consult\u00e9 le 27\u00a0d\u00e9cembre 2024].","key":"10.1016\/j.therap.2024.12.010_bib0240"},{"key":"10.1016\/j.therap.2024.12.010_bib0245","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.pharma.2022.12.005","article-title":"Use of dronabinol in the treatment of resistant neuropathic pain: Feedback from patients followed in a multidisciplinary pain center","volume":"81","author":"Richet","year":"2023","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.therap.2024.12.010_bib0250","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD013444.pub2","article-title":"Dwan K.Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis","author":"Filippini","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.therap.2024.12.010_bib0255","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.38149.566979.AE","article-title":"Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial","volume":"329","author":"Svendsen","year":"2004","journal-title":"BMJ"},{"unstructured":"ANSM. Dossier th\u00e9matique\u00a0\u2013\u00a0mise en place de l\u2019exp\u00e9rimentation du cannabis m\u00e9dical en France. 2024. https:\/\/ansm.sante.fr\/dossiers-thematiques\/cannabis-a-usage-medical\/mise-en-place-de-lexperimentation-du-cannabis-medical [Consult\u00e9 le 27\u00a0d\u00e9cembre 2024].","key":"10.1016\/j.therap.2024.12.010_bib0130"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595724002191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595724002191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T16:07:26Z","timestamp":1754410046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595724002191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0040595724002191"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2024.12.010","relation":{},"ISSN":["0040-5957"],"issn-type":[{"type":"print","value":"0040-5957"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact d\u2019une rupture de dronabinol sur une population de patients douloureux chroniques\u00a0: \u00e9tude observationnelle r\u00e9trospective","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2024.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}